Annual D&A
$0.00
-$72.00 K-100.00%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual depreciation & amortization is $0.00, with the most recent change of -$72.00 thousand (-100.00%) on December 31, 2023.
- During the last 3 years, VYNE annual D&A has fallen by -$341.00 thousand (-100.00%).
- VYNE annual D&A is now -100.00% below its all-time high of $700.00 thousand, reached on December 31, 2019.
Performance
VYNE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 30, 2024
Summary
- VYNE quarterly depreciation & amortization is not available.
Performance
VYNE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 30, 2024
Summary
- VYNE TTM depreciation & amortization is not available.
Performance
VYNE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
VYNE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
VYNE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||||
| 5 y | 5-year | -100.0% | at low | ||||
| alltime | all time | -100.0% | at low |
VYNE Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | $72.00 K(-33.9%) | -$155.00 K(-190.6%) | $72.00 K(-71.5%) |
| Sep 2022 | - | $171.00 K(+1325.0%) | $253.00 K(+130.0%) |
| Jun 2022 | - | $12.00 K(-72.7%) | $110.00 K(-12.7%) |
| Mar 2022 | - | $44.00 K(+69.2%) | $126.00 K(+15.6%) |
| Dec 2021 | $109.00 K(-68.0%) | $26.00 K(-7.1%) | $109.00 K(-35.9%) |
| Sep 2021 | - | $28.00 K(0.0%) | $170.00 K(-18.7%) |
| Jun 2021 | - | $28.00 K(+3.7%) | $209.00 K(-24.0%) |
| Mar 2021 | - | $27.00 K(-69.0%) | $275.00 K(-19.4%) |
| Dec 2020 | $341.00 K(-51.3%) | $87.00 K(+29.9%) | $341.00 K(-20.1%) |
| Sep 2020 | - | $67.00 K(-28.7%) | $427.00 K(-19.4%) |
| Jun 2020 | - | $94.00 K(+1.1%) | $530.00 K(-12.0%) |
| Mar 2020 | - | $93.00 K(-46.2%) | $602.00 K(-14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $700.00 K(+3081.8%) | $173.00 K(+1.8%) | $700.00 K(+29.9%) |
| Sep 2019 | - | $170.00 K(+2.4%) | $539.00 K(+44.5%) |
| Jun 2019 | - | $166.00 K(-13.1%) | $373.00 K(+79.3%) |
| Mar 2019 | - | $191.00 K(+1491.7%) | $208.00 K(+845.5%) |
| Dec 2018 | $22.00 K(+175.0%) | $12.00 K(+200.0%) | $22.00 K(+69.2%) |
| Sep 2018 | - | $4000.00(+300.0%) | $13.00 K(+30.0%) |
| Jun 2018 | - | $1000.00(-80.0%) | $10.00 K(-9.1%) |
| Mar 2018 | - | $5000.00(+66.7%) | $11.00 K(+37.5%) |
| Dec 2017 | $8000.00(+100.0%) | $3000.00(+200.0%) | $8000.00(+60.0%) |
| Sep 2017 | - | $1000.00(-50.0%) | $5000.00(+25.0%) |
| Jun 2017 | - | $2000.00(0.0%) | $4000.00(+100.0%) |
| Mar 2017 | - | $2000.00 | $2000.00 |
| Dec 2016 | $4000.00 | - | - |
FAQ
- What is VYNE Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for VYNE Therapeutics?
- What is VYNE Therapeutics annual D&A year-on-year change?
- What is the all time high quarterly D&A for VYNE Therapeutics?
- What is the all time high TTM D&A for VYNE Therapeutics?
What is VYNE Therapeutics annual depreciation & amortization?
The current annual D&A of VYNE is $0.00
What is the all time high annual D&A for VYNE Therapeutics?
VYNE Therapeutics all-time high annual depreciation & amortization is $700.00 K
What is VYNE Therapeutics annual D&A year-on-year change?
Over the past year, VYNE annual depreciation & amortization has changed by -$72.00 K (-100.00%)
What is the all time high quarterly D&A for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly depreciation & amortization is $191.00 K
What is the all time high TTM D&A for VYNE Therapeutics?
VYNE Therapeutics all-time high TTM depreciation & amortization is $700.00 K